Schroder Investment Management Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$197M Buy
426,341
+5,079
+1% +$2.57M 0.16% 128
2025
Q4
$239M Buy
421,262
+52,560
+14% +$28M 0.18% 102
2025
Q3
$162M Sell
368,702
-57,783
-14% -$27.7M 0.13% 143
2025
Q2
$232M Buy
426,485
+6,692
+2% +$3.5M 0.2% 106
2025
Q1
$208M Sell
419,793
-1,005
-0.2% -$556K 0.21% 104
2024
Q4
$220M Buy
420,798
+23,426
+6% +$12.2M 0.21% 95
2024
Q3
$195M Buy
397,372
+51,331
+15% +$23.9M 0.2% 106
2024
Q2
$154M Buy
346,041
+159,371
+85% +$63.5M 0.17% 113
2024
Q1
$74.5M Buy
186,670
+41,658
+29% +$15.7M 0.09% 209
2023
Q4
$48.9M Buy
145,012
+49,531
+52% +$14.8M 0.06% 278
2023
Q3
$27.9M Buy
95,481
+19,216
+25% +$6M 0.04% 381
2023
Q2
$26.1M Buy
76,265
+19,948
+35% +$6.04M 0.04% 416
2023
Q1
$14.4M Buy
56,317
+17,320
+44% +$4.27M 0.02% 540
2022
Q4
$10.3M Sell
38,997
-134
-0.3% -$32.7K 0.02% 626
2022
Q3
$7.34M Buy
39,131
+3,162
+9% +$679K 0.01% 692
2022
Q2
$7.29M Buy
35,969
+5,961
+20% +$1.4M 0.01% 721
2022
Q1
$9.14M Buy
30,008
+9,138
+44% +$2.67M 0.01% 686
2021
Q4
$7.5M Sell
20,870
-1,924
-8% -$662K 0.01% 661
2021
Q3
$7.55M Buy
22,794
+3,711
+19% +$1.25M 0.01% 692
2021
Q2
$5.85M Buy
19,083
+24
+0.1% +$6.73K 0.01% 798
2021
Q1
$4.7M Buy
19,059
+1,098
+6% +$276K 0.01% 834
2020
Q4
$4.9M Buy
17,961
+1,674
+10% +$416K 0.01% 805
2020
Q3
$3.78M Sell
16,287
-2,505
-13% -$562K 0.01% 773
2020
Q2
$3.57M Buy
18,792
+3,696
+24% +$663K 0.01% 722
2020
Q1
$2.52M Buy
15,096
+8,784
+139% +$1.61M 0.01% 769
2019
Q4
$1.24M Buy
6,312
+2,046
+48% +$383K ﹤0.01% 939
2019
Q3
$759K Buy
4,266
+660
+18% +$114K ﹤0.01% 1012
2019
Q2
$631K Sell
3,606
-2,013
-36% -$345K ﹤0.01% 957
2019
Q1
$1.07M Sell
5,619
-87
-2% -$15.5K ﹤0.01% 890
2018
Q4
$911 Sell
5,706
-15,270
-73% -$2.59M ﹤0.01% 899
2018
Q3
$4.01M Sell
20,976
-10,257
-33% -$1.82M 0.01% 737
2018
Q2
$5.04M Sell
31,233
-28,983
-48% -$4.42M 0.01% 713
2018
Q1
$8.29M Sell
60,216
-11,610
-16% -$1.62M 0.01% 643
2017
Q4
$8.74M Sell
71,826
-64,659
-47% -$8.09M 0.01% 676
2017
Q3
$15.6M Sell
136,485
-3,186
-2% -$347K 0.03% 532
2017
Q2
$14.4M Buy
+139,671
New +$13.4M 0.03% 536
2016
Q3
Sell
-40,860
Closed -$3M 1166
2016
Q2
$3M Buy
+40,860
New +$2.88M 0.01% 788
2015
Q3
Sell
-405
Closed -$22K 1204
2015
Q2
$22K Sell
405
-4,383
-92% -$245K ﹤0.01% 1160
2015
Q1
$264K Sell
4,788
-43,200
-90% -$2.45M ﹤0.01% 1054
2014
Q4
$2.82M Buy
47,988
+2,583
+6% +$144K 0.01% 853
2014
Q3
$2.33M Hold
45,405
﹤0.01% 896
2014
Q2
$2.08M Sell
45,405
-52,083
-53% -$2.3M ﹤0.01% 878
2014
Q1
$4.74M Sell
97,488
-115,200
-54% -$5.43M 0.01% 781
2013
Q4
$9.08M Buy
212,688
+88,200
+71% +$3.71M 0.01% 662
2013
Q3
$5.2M Buy
124,488
+122,688
+6,816% +$5.42M 0.01% 763
2013
Q2
$101K Buy
+1,800
New +$99.2K ﹤0.01% 1287

Other funds holding ISRG

Schroder Investment Management Group's ISRG Position: Q1 2026 in Review

Schroder Investment Management Group increased its Intuitive Surgical (ISRG) stake by 1.2% in Q1 2026, buying an estimated $2.57M and bringing the position to 426,341 shares worth $197M. The position accounts for 0.16% of the portfolio, ranked #128.

Schroder Investment Management Group first reported a position in ISRG in Q2 2013 and has held it in 46 quarters since. The position peaked at $239M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Schroder Investment Management Group held 426,341 shares of Intuitive Surgical worth $197M as of Q1 2026.
  • Schroder Investment Management Group bought 5,079 Intuitive Surgical shares in Q1 2026, an estimated $2.57M.
  • Intuitive Surgical made up 0.16% of Schroder Investment Management Group's portfolio in Q1 2026, its #128 holding.
  • Schroder Investment Management Group first reported a position in Intuitive Surgical in Q2 2013 and has held it in 46 quarters since.
  • Schroder Investment Management Group's Intuitive Surgical position peaked at $239M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.